These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15951177)

  • 21. Congenital myasthenic syndromes.
    Engel AG; Ohno K
    Adv Neurol; 2002; 88():203-15. PubMed ID: 11908226
    [No Abstract]   [Full Text] [Related]  

  • 22. Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up.
    Durmus H; Shen XM; Serdaroglu-Oflazer P; Kara B; Parman-Gulsen Y; Ozdemir C; Brengman J; Deymeer F; Engel AG
    Neuromuscul Disord; 2018 Apr; 28(4):315-322. PubMed ID: 29395675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural abnormalities of the AChR caused by mutations underlying congenital myasthenic syndromes.
    Beeson D; Webster R; Ealing J; Croxen R; Brownlow S; Brydson M; Newsom-Davis J; Slater C; Hatton C; Shelley C; Colquhoun D; Vincent A
    Ann N Y Acad Sci; 2003 Sep; 998():114-24. PubMed ID: 14592868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synaptic dysfunction in congenital myasthenic syndromes.
    Beeson D
    Ann N Y Acad Sci; 2012 Dec; 1275():63-9. PubMed ID: 23278579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission.
    Müller JS; Mihaylova V; Abicht A; Lochmüller H
    Expert Rev Mol Med; 2007 Aug; 9(22):1-20. PubMed ID: 17686188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia.
    Ben Ammar A; Soltanzadeh P; Bauché S; Richard P; Goillot E; Herbst R; Gaudon K; Huzé C; Schaeffer L; Yamanashi Y; Higuchi O; Taly A; Koenig J; Leroy JP; Hentati F; Najmabadi H; Kahrizi K; Ilkhani M; Fardeau M; Eymard B; Hantaï D
    PLoS One; 2013; 8(1):e53826. PubMed ID: 23326516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital myasthenic syndrome: Ten years clinical experience from a quaternary care south-Indian hospital.
    Wadwekar V; Nair SS; Tandon V; Kuruvilla A; Nair M
    J Clin Neurosci; 2020 Feb; 72():238-243. PubMed ID: 31889643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients.
    Milone M; Shen XM; Selcen D; Ohno K; Brengman J; Iannaccone ST; Harper CM; Engel AG
    Neurology; 2009 Jul; 73(3):228-35. PubMed ID: 19620612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromuscular junctions.
    Chevessier F; Girard E; Molgó J; Bartling S; Koenig J; Hantaï D; Witzemann V
    Hum Mol Genet; 2008 Nov; 17(22):3577-95. PubMed ID: 18718936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction.
    Maselli RA; Arredondo J; Cagney O; Ng JJ; Anderson JA; Williams C; Gerke BJ; Soliven B; Wollmann RL
    Hum Mol Genet; 2010 Jun; 19(12):2370-9. PubMed ID: 20371544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK.
    Gallenmüller C; Müller-Felber W; Dusl M; Stucka R; Guergueltcheva V; Blaschek A; von der Hagen M; Huebner A; Müller JS; Lochmüller H; Abicht A
    Neuromuscul Disord; 2014 Jan; 24(1):31-5. PubMed ID: 24183479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7.
    Ben Ammar A; Petit F; Alexandri N; Gaudon K; Bauché S; Rouche A; Gras D; Fournier E; Koenig J; Stojkovic T; Lacour A; Petiot P; Zagnoli F; Viollet L; Pellegrini N; Orlikowski D; Lazaro L; Ferrer X; Stoltenburg G; Paturneau-Jouas M; Hentati F; Fardeau M; Sternberg D; Hantaï D; Richard P; Eymard B
    J Neurol; 2010 May; 257(5):754-66. PubMed ID: 20012313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital myasthenic syndromes.
    Sieb JP; Kraner S; Steinlein OK
    Semin Pediatr Neurol; 2002 Jun; 9(2):108-19. PubMed ID: 12138995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up in patients with congenital myasthenic syndrome due to CHAT mutations.
    Schara U; Christen HJ; Durmus H; Hietala M; Krabetz K; Rodolico C; Schreiber G; Topaloglu H; Talim B; Voss W; Pihko H; Abicht A; Müller JS; Lochmüller H
    Eur J Paediatr Neurol; 2010 Jul; 14(4):326-33. PubMed ID: 19900826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenital myasthenic syndrome due to a novel missense mutation in the gene encoding choline acetyltransferase.
    Schmidt C; Abicht A; Krampfl K; Voss W; Stucka R; Mildner G; Petrova S; Schara U; Mortier W; Bufler J; Huebner A; Lochmüller H
    Neuromuscul Disord; 2003 Mar; 13(3):245-51. PubMed ID: 12609506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Undetermined congenital myasthenic syndromes].
    Nakae M; Sonoda Y
    Ryoikibetsu Shokogun Shirizu; 2001; (36):369-71. PubMed ID: 11596413
    [No Abstract]   [Full Text] [Related]  

  • 37. [Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].
    Andreux F; Hantaï D; Eymard B
    Rev Neurol (Paris); 2004 Feb; 160(2):163-76. PubMed ID: 15034473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards the molecular elucidation of congenital myasthenic syndromes: identification of mutations in MuSK.
    Chevessier F; Faraut B; Ravel-Chapuis A; Richard P; Gaudon K; Bauché S; Prioleau C; Herbst R; Goillot E; Ioos C; Azulay JP; Attarian S; Leroy JP; Fournier E; Legay C; Schaeffer L; Koenig J; Fardeau M; Eymard B; Pouget J; Hantaï D
    Acta Myol; 2005 Oct; 24(2):55-9. PubMed ID: 16550915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and Genetic Features of Congenital Myasthenic Syndromes due to CHAT Mutations: Case Report and Literature Review.
    Arican P; Gencpinar P; Cavusoglu D; Olgac Dundar N
    Neuropediatrics; 2018 Aug; 49(4):283-288. PubMed ID: 29783273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of salbutamol monotherapy in slow-channel congenital myasthenic syndrome caused by a novel mutation in CHRND.
    Tawara N; Yamashita S; Takamatsu K; Yamasaki Y; Mukaino A; Nakane S; Farshadyeganeh P; Ohno K; Ando Y
    Muscle Nerve; 2021 Apr; 63(4):E30-E32. PubMed ID: 33428214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.